Lingating, Esterlita .
HRN: 06-81-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
05/10/2024
05/16/2024
TOPICAL
Apply Thinly
BID
S/P Pig Tail Insertion; Breast CA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes